Upon cisplatin treatment, KD of either the DDB2 or XPC gene increased DNA damage and induced apoptosis in KRAS-mutant NSCLC cells, thereby sensitizing these cells to cisplatin treatment. The gene discussed is XPC; the disease is non-small cell lung carcinoma.